INSPIRE MEDICAL SYSTEMS Q1 Results Beat Estimates, Co Raises FY 2023 Revenue Guidance
May 4, 2023
Trending News ☀️
Inspire Medical Systems ($NYSE:INSP) Inc. is a US-based medical technology company that develops and commercializes innovative treatments for sleep apnea. The company recently reported Q1 results that beat analysts’ estimates, with revenues and earnings both coming in higher than expected. This was driven by continuing growth in sales and new product launches. This was driven by strong demand from both existing and new customers.
Overall, Inspire Medical Systems had an excellent quarter, with revenue, earnings and guidance all beating expectations. The company is well-poised for continued growth, as it continues to develop and launch new technologies to meet the needs of its customers. With the strong performance in Q1, Inspire Medical Systems is well positioned to deliver on its FY 2023 revenue target.
Earnings
In their FY2023 Q1 earnings report, INSPIRE MEDICAL SYSTEMS reported impressive results, with a total revenue of 127.9M USD and a net income loss of 15.42M USD. As a result, INSPIRE MEDICAL SYSTEMS has raised its FY 2023 revenue guidance. This news is sure to delight investors, who are optimistic about the company’s future growth prospects.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for INSP. More…
| Total Revenues | Net Income | Net Margin |
| 466.37 | -43.61 | -9.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for INSP. More…
| Operations | Investing | Financing |
| 11.57 | -19.6 | 235.08 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for INSP. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 571.85 | 67.2 | 17.32 |
Key Ratios Snapshot
Some of the financial key ratios for INSP are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 74.9% | – | -8.9% |
| FCF Margin | ROE | ROA |
| 0.5% | -5.2% | -4.6% |
Stock Price
On Tuesday, INSPIRE MEDICAL SYSTEMS saw its stock move downwards with a 1.8% decrease from the day before. Opening at $260.3 and closing at $257.3, the company had a rather muted day on the stock market. More importantly though, the company saw positive news in its quarterly results. This came as a pleasant surprise to many investors and could have contributed to the company’s lackluster stock performance.
The company is looking forward to continued growth and success for their operations in the near future. With the updated revenue guidance, INSPIRE MEDICAL SYSTEMS is looking to provide a strong outlook for the coming quarters. Live Quote…
Analysis
As GoodWhale, we have conducted an analysis of INSPIRE MEDICAL SYSTEMS’ financials. According to our Star Chart classifications, INSPIRE MEDICAL SYSTEMS is classified as a ‘cheetah’, meaning that it has achieved high revenue or earnings growth but is considered less stable due to lower profitability. As such, this would be attractive to investors looking for high-growth opportunities, while also being aware of the associated risks. In terms of financial health, INSPIRE MEDICAL SYSTEMS has an intermediate health score of 4/10, which is good considering its cashflows and debt. This indicates that the company should be able to sustain future operations in times of crisis. Further analysis reveals that the company is strong in asset and growth, but is weaker in dividend and profitability. Overall, although INSPIRE MEDICAL SYSTEMS might be considered a risky investment due to its lack of stability, it still presents a viable option for investors looking for a high-growth opportunity. More…
Peers
The company’s competitors include ShockWave Medical Inc, InMode Ltd, and INVO Bioscience Inc.
– ShockWave Medical Inc ($NASDAQ:SWAV)
ShockWave Medical Inc is a medical device company that uses shockwave technology to treat cardiovascular disease. The company has a market cap of 9.73B as of 2022 and a return on equity of 19.56%. The company’s products are used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and heart failure.
– InMode Ltd ($NASDAQ:INMD)
InMode Ltd is a medical technology company that develops and manufactures minimally invasive aesthetic solutions. The company has a market capitalization of $2.71 billion as of 2022 and a return on equity of 41.58%. InMode’s products are used by physicians and patients in over 90 countries and the company has a strong presence in the United States, Europe, Asia, and Latin America. InMode’s products are backed by clinical research and have been featured in numerous peer-reviewed journals.
– INVO Bioscience Inc ($NASDAQ:INVO)
INVO Bioscience Inc is a medical device company that has developed a patented in vivo intravaginal culture (IVC) system, which is used to treat infertility. The company’s IVC system is designed to provide a more natural environment for embryo development and is intended to improve the success rates of in vitro fertilization (IVF). INVO Bioscience’s IVC system is currently being used at fertility clinics in the United States and Europe.
Summary
Inspire Medical Systems reported strong Q1 results that exceeded market expectations. In addition, the company continued to make progress on its pipeline of next-generation products. All in all, these results demonstrate that Inspire Medical Systems is well-positioned to continue its impressive growth trajectory in the years ahead.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
